{
    "organizations": [],
    "uuid": "6ca29b26f2aab7d7d851639c600deb0b22a32c6d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-us-fda-accepts-new-drug-applicatio/brief-u-s-fda-accepts-new-drug-application-for-prucalopride-idUSASB0C8SZ",
    "ord_in_thread": 0,
    "title": "BRIEF-U.S. FDA Accepts New Drug Application For Prucalopride",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Shire Plc:\n* U.S. FDA ACCEPTS NEW DRUG APPLICATION FOR PRUCALOPRIDE (SHP555) FOR CHRONIC IDIOPATHIC CONSTIPATION\n* SHIRE PLC - ‍FDA EXPECTED TO PROVIDE DECISION ON OR AROUND DEC 21, 2018, DESIGNATED PRESCRIPTION DRUG USER FEE ACT (PDUFA) ACTION DATE​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-05T23:32:00.000+02:00",
    "crawled": "2018-03-06T22:20:50.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "shire",
        "plc",
        "fda",
        "accepts",
        "new",
        "drug",
        "application",
        "prucalopride",
        "shp555",
        "chronic",
        "idiopathic",
        "constipation",
        "shire",
        "plc",
        "expected",
        "provide",
        "decision",
        "around",
        "dec",
        "designated",
        "prescription",
        "drug",
        "user",
        "fee",
        "act",
        "pdufa",
        "action",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}